Clinical trial
Mirabegron And Ureteral Stent-related Pain (MAP) Trial
NCT04286152 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mirabegron And Ureteral Stent-related Pain (MAP) Trial
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 3, 2020
- Completion date
- June 30, 2021
- Enrollment
- 142 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.